Breaking AI & Tech News Analyzed

The End of LIV Golf as We Know It Confirmation that Saudi Arabia's Public Investment Fund will cease funding the LIV Golf tour will have huge ramifications for the future of the tour itself, the players, and across golf's traditional heartlands. Where does PIF's withdrawal leave them all? Will 2026 be LIV Golf's Final Year? Certainly in its present form, as a 14-event entity worth $30m per tournament. LIV was entirely reliant on Saudi Arabian money, to the tune of more than $5bn since 2021. The cash burn rate, albeit slowed down recently, has always been unsustainable. It is feasible that Scott O'Neil, LIV's chief executive, will find backers for the business at a level which means it can be prolonged in some way. He has already attracted marquee sponsors and overseen significant revenue growth. The Impact on Players Quite the range. There are marquee names: Bryson DeChambeau, Jon Rahm, Cameron Smith, Tyrrell Hatton, Lee Westwood, Dustin Johnson, Ian Poulter and Phil Mickelson among them. There are younger, emerging talents such as José Luis Ballester. Anthony Kim's return from oblivion has been a fascinating tale. What Are Their Options? There is a misconception that LIV golfers will automatically want to beat a path back to the PGA Tour. Some have lingering, ongoing problems with the nature or the style of PGA Tour life. Many have also dedicated a lot of effort and time into making LIV team franchises work. Will the PGA Tour Be Sympathetic? Yes and no. The PGA Tour can flex muscles and portray victory over the rebels if big names shuffle back to its domain. The PGA Tour is also now in a stronger negotiating position than ever in respect of what terms players may have to accept to return. The DP World Tour's Position The long-time theory that the former European Tour should form a business partnership with Saudi Arabia will end as the kingdom abruptly exits male elite golf. A deal with LIV? Not totally out of the question but very difficult to envisage given the strategic alliance that exists between the DP World and PGA Tours. How Should Other Sports View PIF's Withdrawal? With extreme caution. Saudi Arabia did not simply sponsor or assist the LIV Tour. Instead, the circuit was entirely reliant on Public Investment Fund backing. It is unclear to what extent the Iran war has triggered a change in approach from the PIF – it was possible sport was being marginalised anyway – but recent weeks have illustrated the danger of being so beholden to a regime answerable to no one.

The Politicization of Science Donald Trump’s war on science has been vicious and hugely damaging, but it is worth noting that he has lost some of its biggest battles. Last year, Mr Trump demanded that US federal scientific and medical research funding be cut by about half. But the budget Congress passed in February actually delivered a slight increase in overall funding – although specific Trump targets such as the Centers for Disease Control and Prevention were cut. Resistance from Congress He also continues to chip away at science in other ways such as dismissing the board overseeing the National Science Foundation this week. Maga’s attacks on science have been nakedly political. Its defeats have been politics of a different sort, showing that the bipartisan pro-science consensus is still intact, and for the moment has the power to hold Mr Trump in check. A Global Trend What is happening in the US is not unique. Wherever rightwing populists triumph, science is likely to suffer. Jair Bolsonaro’s rule in Brazil saw him attack scientists and cut environmental funding. In India, Narendra Modi’s Hindu nationalist government purged the theory of evolution from school textbooks. In Britain, Reform UK has already attempted local government cuts, targeting net zero spending. The Changing Role of Scientists Scientists have tended to avoid party politics for a specific reason. Historians identify an implicit scientific social contract that emerged in western states after the second world war, which established the state as the main funder of research, but in theory discouraged direct political interference by government. Many scientists believe that engaging in politics endangers this compact: if scientists don’t bother politics, it won’t bother them. A New Era for Science and Politics Scientists are no longer just defending funding. They are defending the idea that science should be independent of politics. What scientists gain by organising protests, speaking to the public through their academies and now running for office is a better understanding of the changing public sphere that they are part of. The public may gain an ally against rightwing populism – and a deeper, more serious engagement with the scientific challenges facing society. Mr Trump set out to tame scientists. He may have politicised them instead.

The Journey from Prototype to ClearanceBuilding a medical device is fundamentally different from standard software development. This week on Build Mode, host Isabelle Johannessen sat down with Robhy Bustami, co-founder and CEO of BioticsAI, to discuss the arduous path from a $100,000 prototype to FDA clearance. Bustami, a Startup Battlefield winner, detailed how his team is building an AI copilot for ultrasound designed to detect fetal abnormalities. The conversation revealed that the traditional startup mantra of 'move fast and break things' is obsolete in the medical sector, replaced by a necessity for extreme precision and coordination.Market Validation and Resource AllocationThe episode provides a strategic look at the 'data' driving medtech success. BioticsAI's recognition as a Startup Battlefield winner serves as a key validation of their technology's potential. However, Bustami emphasized that the primary data point for founders is not just market traction, but the successful navigation of complex regulatory pathways. This requires a significant reallocation of resources—shifting focus from rapid feature deployment to ensuring safety, reliability, and compliance with FDA standards.Shifting the MedTech CultureThe core impact of this discussion lies in the cultural shift it highlights for the industry. As timelines for FDA approval remain uncertain, the ability to maintain team morale and investor confidence becomes a critical operational metric. Bustami noted that building in a regulated industry requires a foundation of trust rather than speed. This signals a broader trend where medtech startups must balance the pressure of hyper-growth with the ethical and legal responsibilities of patient safety.The Future of AI in Healthcare RegulationLooking ahead, the medtech landscape will likely see a consolidation of companies that prioritize long-term compliance over short-term hype. As more AI copilots enter the market, the winners will be those founders who master the art of 'slow and steady' innovation. The next wave of medical breakthroughs will depend not just on algorithmic superiority, but on the ability to build sustainable organizations capable of weathering the regulatory storm.

The Challenges of FDA Approval Surviving the long road to FDA approval isn’t just about building great technology — it’s about keeping your team motivated, finding the right investors, and learning how to operate when timelines are uncertain. Lessons from BioticsAI This week on Build Mode, Isabelle Johannessen sits down with Robhy Bustami, co-founder and CEO of BioticsAI, a Startup Battlefield-winning company building an AI copilot for ultrasound to help detect fetal abnormalities. From a $100,000 prototype to FDA clearance, Bustami shares what it actually takes to build in one of the most regulated industries in the world. Building a Medtech Startup In this episode, they break down what it really looks like to build a medtech startup, including where you can’t “move fast and break things” and that every milestone takes time, coordination, and trust. Key Takeaways Team motivation is crucial during the long FDA approval process Finding the right investors is essential for medtech startups Adaptability is key when dealing with uncertain timelines Future Outlook As the medtech industry continues to evolve, startups like BioticsAI will play a critical role in shaping the future of healthcare technology. With the right approach and mindset, these companies can overcome the challenges of FDA approval and make a lasting impact.

The Trial Continues Elon Musk's court case against Sam Altman continues on Thursday, after a day of contentious exchanges during OpenAI's cross-examination of the Tesla CEO. Musk will face another round of questioning before his lawyer calls more witnesses, including OpenAI's president, Greg Brockman. The Dispute Over OpenAI's Founding Witness testimony and evidence has revealed formerly private emails, text messages and diary entries surrounding the formation of OpenAI, giving a behind-the-scenes look at how the tech behemoth was created. Many of the tech industry's most powerful players are named as witnesses and will give their account on the origins of Musk and Altman's bitter feud. Altman is set to testify later in the trial, which will last three weeks. Musk's Allegations Against OpenAI Musk, who co-founded OpenAI in 2015, is arguing that Altman, Brockman and OpenAI broke a foundational agreement when they shifted the company from a non-profit intent on bettering humanity into a for-profit structure. Musk claims that Altman and Brockman unjustly enriched themselves and should be removed from the company. He is also seeking the undoing of the for-profit conversion and $134bn in damages to be redirected to OpenAI's non-profit arm. OpenAI's Response OpenAI rejects Musk's allegations and is attempting to show that he was always aware of plans for creating a for-profit entity. The AI firm's attorneys have stated Musk is "motivated by jealousy" of OpenAI's success after he left the company in 2018 after a failed attempt to take control. OpenAI has emphasized that it is still overseen by a non-profit. The Implications of the Trial The trial, which began on Monday with jury selection at a federal courthouse in Oakland, California, has already produced dramatic moments and bold accusations. Musk and OpenAI's lead attorney William Savitt spent most of Wednesday in a heated back and forth, with the world's richest person becoming noticeably frustrated and saying that Savitt's questions "are designed to trick me". The Future of OpenAI Silicon Valley is intently watching the trial for both its blockbuster testimony and the potential effects it will have on the AI industry. OpenAI is intending to go public later this year at around a $1tn valuation, but if Musk succeeds in this case, it could greatly complicate that effort – an outcome that would also benefit Musk's own xAI artificial intelligence firm.

Salesforce's AI Roadmap Strategy Artificial intelligence continues to advance at a dizzying clip, forcing enterprises to develop and release new products quicker than ever or risk becoming irrelevant to a faster-moving competitor. Salesforce believes it has found a strategy that allows it to keep up even if it isn’t clear where AI is headed next. The customer management software giant is crowdsourcing its AI roadmap in real time. Crowdsourcing AI Development Salesforce is certainly not the only company to work intimately with its customers for feedback on its products. However, it’s notable considering the sheer size of the company, the pace of new product launches or fixes to existing ones, and the granular level of these relationships. These aren’t annual or even quarterly discussions. Salesforce is meeting with some customers as often as once a week. The Benefits of Customer Feedback “The 18,000 customers are a wellspring of information and a wealth of information that is really needed to get to customer success,” Jayesh Govindarajan, executive vice president at Salesforce AI, told TechCrunch in a recent interview. “The stack that we’ve built has resonated with these customers. Over time we can get context to be better, and as it gets better, and LLMs get better, agent systems do more and more fully autonomous behaviors. That’s a long-running innovation track and we’re going to invest in that.” Rapid Product Releases Salesforce credits its customers for the rate of its product releases. The company told TechCrunch that by letting its customers lead the way, it is able to build an AI product roadmap that can quickly react to where AI technology is headed. Real-World Applications Engine, a travel management platform, meets with Salesforce weekly and gets access to AI tools before they’re released. PenFed, a federal credit union, developed an IT service management (ITSM) workflow on its own using existing tools and agents in Agentforce. The Future of AI Development This strategy also allows the company to roll out solutions and workflows built by users to its broader customer base too. However, it relies on the classic service sentiment that the customer is always right. Salesforce is hoping they are despite many enterprises still figuring out what role AI will play in their business, and many having yet to find value from the tech.

Saudi PIF Announces End of Funding After the 2026 SeasonThe Public Investment Fund (PIF) confirmed that its financial support for the breakaway LIV Golf league will stop at the close of the 2026 season. In a statement, PIF said the “substantial investment required over a longer term is no longer consistent with the current phase of PIF’s investment strategy.”New LIV Golf Board Targets a Multi‑Partner Investment ModelGene Davis of Pirinate Consulting Group and Jon Zinman of JZ Advisors have been appointed to a newly created board, with Davis serving as chair. Their mandate is to secure long‑term financial partners to replace Saudi capital, while a committee of independent directors will explore strategic alternatives beyond the PIF horizon.Financial Footprint: $5.3 bn Spent Since Launch$1 bn allocated to marquee contracts for players such as Bryson DeChambeau, Brooks Koepka, Phil Mickelson, Cameron Smith and Jon Rahm.$5.3 bn spent by LIV Golf from its 2022 launch; projected to reach $6 bn by year‑end.$30 m prize fund per tournament.Goal for 10 of 13 teams to be profitable this year.Implications for the Global Golf LandscapeThe funding withdrawal reshapes the power balance between LIV Golf and the established PGA Tour. Without PIF backing, LIV must prove its franchise‑team model can attract alternative capital, a challenge that could affect player retention, especially for top signings like DeChambeau and Rahm. The PGA Tour, meanwhile, continues to negotiate pathways for former LIV players, offering limited‑time returns but with strict conditions.Outlook: Funding Strategies and Player RetentionAnalysts expect LIV Golf to pursue a consortium of private investors, media rights deals, and possibly a public‑stock component to sustain operations beyond 2026. Success will hinge on delivering consistent profitability across its teams and maintaining the allure of its $30 m prize pools. If alternative financing falls short, the league may face a talent exodus as contracts expire, potentially accelerating a convergence with the PGA Tour’s ecosystem.

Careless People by Sarah Wynn‑Williams is an audiobook memoir that pulls back the curtain on her seven years inside Meta (formerly Facebook) and the legal gag order that tried to keep the story quiet.The Insider’s Tale: A Memoir of Meta’s Dark SideBegins with a childhood shark‑attack that shaped Wynn‑Williams’s worldview.Joined Meta’s public‑policy team in 2011, witnessing unchecked power, privacy neglect, and a 24/7 “always‑on” work culture.Features an introduction by Naomi Alderman, who explains the contractual gag order imposed by Meta.Numbers Behind the Narrative: Awards, Length, and ReachAudio runtime: 13 hr 26 min.Winner of the 2025 British Audio Award for nonfiction.Published by Macmillan.Why This Memoir Matters: Cultural and Ethical Implications for TechExposes how senior staff at a leading tech platform prioritized rapid expansion over privacy and misinformation concerns.Highlights the personal toll on employees, including responding to emails while in labour.Illustrates the use of contractual clauses to suppress whistle‑blowing, raising questions about legal protections for former staff.Looking Ahead: What Careless People Signals for Future WhistleblowingSets a precedent for insiders to narrate their experiences directly, bypassing traditional publishing constraints.May encourage stricter scrutiny of gag orders and push regulators to consider new safeguards for employee speech.Signals a growing appetite for transparent, first‑hand accounts of tech‑industry culture.

The End of an Era at Burnley Burnley Football Club has confirmed that Scott Parker has departed the club, with his contract being terminated by mutual agreement. This move comes as no surprise given Burnley's dismal performance in the Premier League this season, which has all but sealed their fate for relegation to the Championship. Parker's Tenure at Burnley Scott Parker took the reins at Burnley two years ago, leading the team to promotion from the Championship to the Premier League. His success was built on a rock-solid defense, with the team losing just two matches in 46 during the previous season. However, this season has been a different story, with Burnley struggling to cope with the demands of the top flight. The Data Tells the Story Burnley has won just four top-flight matches this season. The team has conceded goals at a rate of two per game. Despite having a year left on his contract, Parker has decided to leave the club. What's Next for Burnley? Michael Jackson, a member of Parker's staff, has been appointed as interim head coach to oversee the remainder of the season. This will be a challenging period for Burnley as they look to regroup and plan for the Championship next season. The Future for Scott Parker As for Parker, his future in football management remains uncertain. While he has proven himself to be an excellent Championship manager, he has yet to demonstrate his capabilities in the Premier League. The question on everyone's lips is: where will Parker end up next?